Detected ·
Mironid® Limited
$46M—
Mironid® Limited, a Scottish biopharma developing small molecule therapeutics for ADPKD (Autosomal Dominant Polycystic Kidney Disease), raised $46M in Series B financing led by the Scottish National Investment Bank, alongside Roche Venture Fund, Epidarex Capital, Sofinnova Partners, BGV, and the University of Strathclyde.
- Website
- —
- Amount
- $46 000 000 USD
- Stage
- —
- Event
- Funding round
- Detected
- 2026-08-10 16:01:26 UTC
- Signal ID
- 7bf8cece-5e1d-4f7e-aeac-1ee84e9f3586
As the API returns it
{
"id": "7bf8cece-5e1d-4f7e-aeac-1ee84e9f3586",
"created_at": "2026-08-10T16:01:26.031893Z",
"company_name": "Mironid® Limited",
"company_website_url": null,
"company_linkedin_url": "https://www.linkedin.com/company/mironid-limited",
"event_type": "funding",
"funding_amount": 46000000,
"funding_currency": "USD",
"funding_stage": null,
"message": "*Mironid® Limited, a Scottish biopharma developing small molecule therapeutics for ADPKD (Autosomal Dominant Polycystic Kidney Disease), raised $46M in Series B financing led by the Scottish National Investment Bank, alongside Roche Venture Fund, Epidarex Capital, Sofinnova Partners, BGV, and the University of Strathclyde.*"
}